rs1057519643
Variant summary
Our verdict is Uncertain significance. The variant received 5 ACMG points: 5P and 0B. PM1PM2PP5
The NM_015295.3(SMCHD1):c.408A>C(p.Glu136Asp) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. E136E) has been classified as Likely benign.
Frequency
Consequence
NM_015295.3 missense
Scores
Clinical Significance
Conservation
Publications
- arhinia, choanal atresia, and microphthalmiaInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, G2P, Ambry Genetics, ClinGen, Illumina
- facioscapulohumeral muscular dystrophyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hyposmia-nasal and ocular hypoplasia-hypogonadotropic hypogonadism syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 5 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SMCHD1 | NM_015295.3 | c.408A>C | p.Glu136Asp | missense_variant | Exon 3 of 48 | ENST00000320876.11 | NP_056110.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SMCHD1 | ENST00000320876.11 | c.408A>C | p.Glu136Asp | missense_variant | Exon 3 of 48 | 5 | NM_015295.3 | ENSP00000326603.7 | ||
| SMCHD1 | ENST00000688342.1 | c.408A>C | p.Glu136Asp | missense_variant | Exon 3 of 47 | ENSP00000508422.1 | ||||
| SMCHD1 | ENST00000684915.1 | n.565A>C | non_coding_transcript_exon_variant | Exon 3 of 14 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Arrhinia with choanal atresia and microphthalmia syndrome Pathogenic:3
- -
- -
The variant is not observed in the gnomAD v2.1.1 dataset. Predicted Consequence/Location: The variant is located in a mutational hot spot and/or well-established functional domain in which established pathogenic variants have been reported. Missense changes are a common disease-causing mechanism. Damaging effect on gene or gene product predicted by in silico programs is uncertain [REVEL: 0.13 (damaging >=0.6, benign <0.4), 3Cnet: 0.16 (damaging >=0.6, benign <0.15), Splice AI: NA (spliceogenicity >=0.2, non-spliceogenicity <0.1)]. Same nucleotide change resulting in same amino acid change has been previously reported to be associated with SMCHD1 related disorder (ClinVar ID: VCV000375764 /PMID: 28067909). However, the evidence of pathogenicity is insufficient at this time. A different missense change at the same codon (p.Glu136Gly) has been reported to be associated with SMCHD1 related disorder (PMID: 28067911). Therefore, this variant is classified as Likely pathogenic according to the recommendation of ACMG/AMP guideline. -
Facioscapulohumeral muscular dystrophy 2 Pathogenic:1Uncertain:1
This sequence change replaces glutamic acid, which is acidic and polar, with aspartic acid, which is acidic and polar, at codon 136 of the SMCHD1 protein (p.Glu136Asp). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with clinical features of SMCHD1-related conditions (PMID: 28067909). ClinVar contains an entry for this variant (Variation ID: 375764). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on SMCHD1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at